These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24685694)

  • 1. miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway.
    Wei Z; Cui L; Mei Z; Liu M; Zhang D
    FEBS Lett; 2014 May; 588(9):1773-9. PubMed ID: 24685694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT1 Inhibits MiR-181a Expression to Suppress Colorectal Cancer Cell Proliferation Through PTEN/Akt.
    Zhang X; Li X; Tan F; Yu N; Pei H
    J Cell Biochem; 2017 Oct; 118(10):3435-3443. PubMed ID: 28322462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer.
    Li Z; Wang H; Xu Z; Sun Y; Han J
    Oncol Rep; 2016 Mar; 35(3):1403-8. PubMed ID: 26750720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.
    Zhai Z; Mu T; Zhao L; Li Y; Zhu D; Pan Y
    Bioengineered; 2022 Jan; 13(1):83-95. PubMed ID: 34951340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism.
    Zheng H; Liu J; Tycksen E; Nunley R; McAlinden A
    Bone; 2019 Jun; 123():92-102. PubMed ID: 30898695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1β/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis.
    Hai Ping P; Feng Bo T; Li L; Nan Hui Y; Hong Z
    Arch Biochem Biophys; 2016 Aug; 604():20-6. PubMed ID: 27264420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-495 mediates metabolic shift in glioma cells via targeting Glut1.
    Nie S; Li K; Huang Y; Hu Q; Gao X; Jie S
    J Craniofac Surg; 2015 Mar; 26(2):e155-8. PubMed ID: 25759932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.
    Chen HH; Huang WT; Yang LW; Lin CW
    Am J Pathol; 2015 May; 185(5):1487-99. PubMed ID: 25907832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.
    Wang L; Yu Z; Ren S; Song J; Wang J; Du G
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2281-2292. PubMed ID: 30036603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-382 targeting PTEN-Akt axis promotes liver regeneration.
    Bei Y; Song Y; Wang F; Dimitrova-Shumkovska J; Xiang Y; Zhao Y; Liu J; Xiao J; Yang C
    Oncotarget; 2016 Jan; 7(2):1584-97. PubMed ID: 26636539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway.
    Eichner LJ; Perry MC; Dufour CR; Bertos N; Park M; St-Pierre J; Giguère V
    Cell Metab; 2010 Oct; 12(4):352-361. PubMed ID: 20889127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell-conditioned medium alleviates high fat-induced hyperglucagonemia via miR-181a-5p and its target PTEN/AKT signaling.
    Song J; He Q; Guo X; Wang L; Wang J; Cui C; Hu H; Yang M; Cui Y; Zang N; Yan F; Liu F; Sun Y; Liang K; Qin J; Zhao R; Wang C; Sun Z; Hou X; Li W; Chen L
    Mol Cell Endocrinol; 2021 Nov; 537():111445. PubMed ID: 34464683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN/Akt signaling pathway.
    Liao C; Chen W; Fan X; Jiang X; Qiu L; Chen C; Zhu Y; Wang H
    Oncol Res; 2013; 21(3):129-36. PubMed ID: 24512727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.
    Iliopoulos D; Jaeger SA; Hirsch HA; Bulyk ML; Struhl K
    Mol Cell; 2010 Aug; 39(4):493-506. PubMed ID: 20797623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
    Yang H; Kong W; He L; Zhao JJ; O'Donnell JD; Wang J; Wenham RM; Coppola D; Kruk PA; Nicosia SV; Cheng JQ
    Cancer Res; 2008 Jan; 68(2):425-33. PubMed ID: 18199536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
    Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNFα-Induced Insulin Resistance.
    Lozano-Bartolomé J; Llauradó G; Portero-Otin M; Altuna-Coy A; Rojo-Martínez G; Vendrell J; Jorba R; Rodríguez-Gallego E; Chacón MR
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1447-1458. PubMed ID: 29409019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.